checkAd
    Startseite > Aktien > Taysha Gene Therapies > Nachrichten
    Taysha Gene Therapies
    Aktie
    ISIN: US8776191061 WKN: A2QCJL SYM: TSHA Land USA
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    4,1700
     
    USD
    +6,65 %
    +0,2600 USD
    Letzter Kurs 02:00:00 Nasdaq
    Geldkurs
    13.06.24
    4,1500
     
    USD
    2.700 STK
    Briefkurs
    13.06.24
    4,1700
     
    USD
    3.000 STK

    Taysha Gene Therapies Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting
    12.06.24 · globenewswire · Taysha Gene Therapies
    Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    07.06.24 · globenewswire · Taysha Gene Therapies
    Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
    14.05.24 · globenewswire · Taysha Gene Therapies
    Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
    07.05.24 · globenewswire · Taysha Gene Therapies
    Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    03.05.24 · globenewswire · Taysha Gene Therapies
    Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
    02.05.24 · globenewswire · Taysha Gene Therapies
    Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    05.04.24 · globenewswire · Taysha Gene Therapies
    Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates
    19.03.24 · globenewswire · Taysha Gene Therapies
    Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19
    14.03.24 · globenewswire · Taysha Gene Therapies
    Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    01.03.24 · globenewswire · Taysha Gene Therapies
    Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome
    29.02.24 · globenewswire · Taysha Gene Therapies
    Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs
    15.02.24 · globenewswire · Taysha Gene Therapies